Indiba Medical Technology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Indiba Medical Technology - overview
Established
1983
Location
-, -, Spain
Primary Industry
Medical Devices & Equipment
About
Indiba Medical Technology is a Spanish company specializing in advanced radiofrequency and laser technologies for medical aesthetics, health, sports, and veterinary applications, providing innovative solutions across diverse markets. Founded in 1983 in Spain, Indiba Medical Technology develops radiofrequency technology for medical and aesthetic treatments. In December 2017, Magnum Capital Industrial Partners acquired a majority stake in the company for EUR 55 mn. The firm has completed four deals to date, with its latest transaction occurring in December 2017.
The CEO is Remco Schmitz. Indiba specializes in innovative solutions in aesthetics, health, sports, and veterinary medicine, primarily through radiofrequency technology and laser devices. Their core products include the K-Laser series for pain relief and the COMPACT line for rehabilitation and aesthetic treatments. The company serves healthcare professionals, aesthetic practitioners, and veterinarians in Europe, Asia, and North America, targeting needs in medical aesthetics, intimate health, and animal health.
In the most recent fiscal year of 2022, Indiba reported a revenue of EUR 10,579,048. 40 and an EBITDA of EUR -419,357. 50, demonstrating their operational performance in the medical technology sector. Indiba aims to enhance its product offerings with upcoming launches focused on advanced radiofrequency applications by 2025.
The company plans to expand into new geographic markets, particularly in Asia and North America, to increase its reach by 2024. The funding from the Secondary Buyout in December 2017, valued at EUR 55 mn, will support these initiatives by enhancing product development and marketing strategies.
Current Investors
Magnum Capital Industrial Partners
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.indiba.es
Verticals
HealthTech
Company Stage
Mature
Total Amount Raised
Subscriber access only
Indiba Medical Technology - timeline of key events
Indiba Medical Technology - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 16,887,550.3 | 16,274,091.1 | 19,215,881.4 | 22,436,421.1 | 26,032,586.5 | 20,777,524.1 | 32,891,947.6 | - | - | - |
| % Revenue Growth (YoY) | - | (3.6%) | 18.1% | 16.8% | 16.0% | (20.2%) | 58.3% | - | - | - |
| EBITDA (USD) | 4,090,121.5 | 3,906,898.6 | 6,466,486.4 | 8,031,434.8 | 10,193,655.3 | 6,807,190.6 | 12,230,714.1 | - | - | - |
| Operating Income (USD) | 3,418,661.8 | 2,565,711.8 | 4,946,868.2 | 6,288,922.9 | 8,533,453.1 | 4,985,183 | 10,181,725.2 | - | - | - |
| Operating Margin | 20.2% | 15.8% | 25.7% | 28.0% | 32.8% | 24.0% | 31.0% | - | - | - |
| % EBITDA Margin | 24.2% | 24.0% | 33.7% | 35.8% | 39.2% | 32.8% | 37.2% | - | - | - |
| NET Income (USD) | 2,757,975.8 | 848,373.7 | 2,994,646.1 | 3,911,160.5 | 5,160,680.5 | 1,357,533.2 | 6,998,381.7 | - | - | - |
| % Net Margin | 16.3% | 5.2% | 15.6% | 17.4% | 19.8% | 6.5% | 21.3% | - | - | - |
Indiba Medical Technology - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | Indiba Medical Technology | - | ||||||||
| Secondary Buyout | Completed | Indiba Medical Technology | - | ||||||||
| Private Debt | Completed | Indiba Medical Technology | - | ||||||||
| Buyout | Completed | Indiba Medical Technology | - |
Displaying 1 - 4 of 4
Indiba Medical Technology - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.